Chengcai An

Title: Chengcai An: Innovator in Anti-Tumor Research

Introduction

Chengcai An is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of anti-tumor agents. His innovative work focuses on enhancing the efficacy and safety of therapeutic compounds.

Latest Patents

Chengcai An holds a patent for "Mutants of trichosanthin with anti-tumor activity and lowered side-effects." This invention provides mutants and coding genes of trichosanthin (TCS). The TCS mutants feature single or double alterations of tyrosine-55 and aspartate-78, where tyrosine-55 is mutated to an aliphatic amino acid and aspartate-78 is mutated to an amino acid with low hydrophilicity. This invention also relates to the application of TCS mutants and their coding genes in drug development for treating carcinoma, AIDS, and other diseases. He has 1 patent to his name.

Career Highlights

Chengcai An has dedicated his career to advancing medical research and developing innovative solutions for complex health issues. His work has garnered attention for its potential impact on cancer treatment and other serious conditions.

Collaborations

Chengcai An has collaborated with notable colleagues in his field, including Shuangli Mi and Ye Wy Wang. Their combined expertise contributes to the advancement of research and development in biotechnology.

Conclusion

Chengcai An is a key figure in the realm of anti-tumor research, with a focus on creating safer and more effective treatments. His contributions are paving the way for future innovations in medical science.